IMMUCELL CORPICCC

時価総額

$2813.6万

PER

	2013年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日
Cash and cash equivalents	2	6	7	10	6
Trade accounts receivable, net	631,410	2	2	3	2
Inventory	1	3	2	3	6
Total	-	259,566	321,261	295,197	406,055
Total current assets	7	13	12	16	14
Property, plant and equipment, net	3	25	27	27	28
Operating lease right-of-use asset	-	-	1	1	2
Goodwill	-	95,557	95,557	95,557	95,557
Intangible assets, net	-	114,624	95,520	76,416	57,312
Other assets	13,636	26,884	26,173	26,115	76,628
TOTAL ASSETS	11	39	40	44	45
Current portion of debt obligations	190,390	1	760,337	812,207	1
Current portion of operating lease liability	-	-	100,512	108,012	31,764
Total	-	1	1	2	2
Total current liabilities	635,619	2	2	3	3
Debt obligations, net of current portion	896,224	7	9	8	9
Operating lease liability, net of current portion	-	-	1	1	2
Total long-term liabilities	929,226	7	10	9	11
TOTAL LIABILITIES	2	10	12	12	14
Common stock, $0.10 par value per share, 15,000,000 shares authorized and 7,814,165 shares issued as of both December 31, 2022 and 2021 and 7,746,864 and 7,741,864 shares outstanding as of December 31, 2022 and 2021, respectively	326,115	729,901	729,901	781,417	781,417
Additional paid-in capital	-	31	31	36	36
Accumulated deficit	-407,408	-2,638,285	-3,660,402	-3,738,694	-6,232,499
Treasury stock, at cost, 67,301 and 72,301 shares as of December 31, 2022 and 2021, respectively	514,341	188,336	175,392	158,171	147,233
Total stockholders’ equity	9	29	28	33	30
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	11	39	40	44	45